Covid: Maharashtra, Delhi, WB, TN emerging as states of concern, says govt

Eight districts reporting over 10% Covid weekly positivity; 14 districts reporting positivity between 5%-10%, says govt

Omicron
A health official takes swab sample of a person on a street for COVID-19 test, amid concern over rising Omicron cases, in New Delhi (Photo: PTI)
Press Trust of India New Delhi
2 min read Last Updated : Dec 30 2021 | 5:14 PM IST

The government on Thursday said that Maharashtra, West Bengal, Tamil Nadu, Delhi, Karnataka and Gujarat are emerging as states and UTs of concern on the basis of weekly COVID-19 cases and positivity rate.

It said that eight districts are reporting over 10 per cent weekly positivity, while 14 districts are reporting between 5-10 per cent positivity.

India's R naught value, which indicates spread of COVID-19, is 1.22 so cases are increasing, not shrinking, the government said.

The country has reported more than 10,000 daily new COVID-19 cases after 33 days, it said stressing that there is a need for heightened vigil in view of sharp increase in infections.

Evidence shows that Omicron variant has a growth advantage over Delta with doubling time of 2-3 days, the government said quoting the WHO.

It said the durability of immunity post COVID-19 infection persists for about 9 months.

The government said 90 per cent of India's adult population has been administered the first dose of the coronavirus vaccine and 63.5 per cent people are now fully vaccinated.

The precautionary dose of the vaccine is primarily to mitigate severity of infection, hospitalisation and death, it said.

The government said that masking before and after vaccination is a must. It said that earlier and currently circulating strains of coronavirus spread through the same routes and added that treatment guidelines for the infection remain the same.

It said that the whole virus infects an individual in natural settings and added that it elicits cell mediated immunity and immunological memory.

The government said that within one month 3,30,379 cases of Omicron variant and 59 deaths were reported across 121 countries.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronCoronavirus Vaccine

First Published: Dec 30 2021 | 5:12 PM IST

Next Story